iBio Financials - Benzinga

iBio Inc

IBIONASDAQ

Trade with Public

Trade with Public

$1.25

-0.085-6.39%

al cierre: Sep 23, 5:00 PM EST

$1.25

0.0050.4%

After hour: 5:25 PM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Informe de acciones

iBio Financials

iBio (IBIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
iBio Q3 EPS $(0.07) Misses $(0.06) Estimate

iBio (AMEX:IBIO) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 85.71 percent increase over losses of $(0.49) per share from the same

Benzinga Newsdesk

iBio Earnings Review: Q2 Summary

Benzinga Insights

PRO
iBio Q2 EPS $(0.09) Misses $(0.07) Estimate

iBio (AMEX:IBIO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 81.25 percent increase over losses of $(0.48) per share from the same

Benzinga Newsdesk

PRO
iBio Q1 EPS $(0.11) Misses $(0.10) Estimate, Sales $100.000K Beat $25.000K Estimate

iBio (AMEX:IBIO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 7.84 percent. This is a 76.09 percent increase over losses of $(0.46) per share from the same

Benzinga Newsdesk

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings

Avi Kapoor

PRO
iBio Q3 EPS $(0.49) Misses $(0.34) Estimate

iBio (AMEX:IBIO) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.34) by 44.12 percent. This is a 30.99 percent increase over losses of $(0.71) per share from the same

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved